A clinical study to evaluate the effectiveness of Khadirashtak kwath in shitapitta.

Clinical evaluation of the efficacy of Khadirashtak kwath in the management of shitapitta w.s.r to urticaria a randomised controlled trial. - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101304

Enrollment

Registered

2026-01-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with classical symptoms of urticaria. 2.Age group:- 20-50 years. 3.Patients will be selected irrespective of gender, occupation and socioeconomic status .

Exclusion criteria

Exclusion criteria: 1.Patients with any major systemic disease. 2.Pregnant and lactating mother. 3.History of any known drug allergy. 4.Patients with co-morbidities. 5.Patients with skin disorders other than shitapitta.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Khadirashtak kwath in the management of Shitapitta.Timepoint: 42 days	—

Secondary

Measure	Time frame
1)To study about the Nidan Panchaka of Shitapitta described in Ayurveda and correlate it with modern science. 2)To compare Khadirashtak kwath with Amrutadi kwath in the management of Shitapitta. 3)To evolve cost effective treatment helpful in the management of Shitapitta.Timepoint: 42 days	—

Countries

India

Contacts

Public ContactDr Naresh Gehlot

Radhakisan Toshniwal Ayurved Mahavidyalaya

drsadhana.k@gmail.com9422939510

Outcome results